OakChart

Varex Imaging Corp

VREXHealthcare·Medical Devices·USA·Small·NASD·Nov 11 • 11:15 AM ET

18.46+0.01 (0.05%)
2026-11-11 17:15 CET
Market cap
783.45 USD m
Revenue, TTM
865.00 USD m
Net income, TTM
22.10 USD m
Free cash flow, TTM
-20.20 USD m
EPS diluted, TTM
0.52
P/E
35.37
Compare

Price

VREX against its 20, 50 and 200-day averages
2050200beat
10.0012.5015.0017.506.6M13.2MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26VREXclose 18.4620-day 18.4450-day 18.46200-day 13.7818.4652w low

0.9% under the 52-week high of 18.63 on 11 Aug 2026. 52-week low 9.09 on 8 May 2026. Last 15 sessions, 1.1% high to low

Profile

VREX
52-week range, 98% of the way up
9.0918.63

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded on July 18, 2016 and is headquartered in Salt Lake City, UT.

IndexRUT
Employees2400
IPOJan 20, 2017
Beta1.03
ATR, 14d0.06
Rel volume0.27
Short float4.87%
Insider own1.72%
Inst own81.47%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap783.88M
Enterprise Value1.08B
Income22.10M
Sales865.00M
Book/sh11.78
Cash/sh2.34
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees2400
IPOJan 20, 2017

Ratios

P/E35.37
Forward P/E17.25
PEG-
P/S0.91
P/B1.57
P/C7.90
P/FCF-
EV/EBITDA10.83
EV/Sales1.25
Quick Ratio1.53
Current Ratio3.38
Debt/Eq0.76
LT Debt/Eq0.72
Option/ShortYes / Yes

Earnings

EPS (ttm)0.52
EPS next Y1.07
EPS next Q0.29
EPS this Y-6.67%
EPS next Y27.38%
EPS next 5Y-
EPS past 3/5Y- -2.62%
Sales past 3/5Y-0.58% 2.73%
EPS Y/Y TTM116.46%
Sales Y/Y TTM5.31%
EPS Q/Q117.16%
Sales Q/Q3.69%
EarningsAug 10 BMO
EPS/Sales Surpr.47.55% -2.32%

Ownership

Insider Own1.72%
Insider Trans-15.90%
Inst Own81.47%
Inst Trans-10.12%
ROA2.03%
ROE4.64%
ROIC2.59%
Gross Margin34.32%
Oper. Margin8.35%
Profit Margin2.55%
SMA200.09%
SMA500.00%
SMA20033.96%
Trades-

Technical

Shs Outstand42.15M
Shs Float41.73M
Short Float4.87%
Short Ratio2.84
Short Interest2.03M
52W High18.63 -0.91%
52W Low9.09 103.08%
Volatility0.25% 0.29%
ATR (14)0.06
RSI (14)58.01
Beta1.03
Rel Volume0.27
Avg Volume714.88K
Volume58,745

Performance

Perf Week-0.27%
Perf Month-0.05%
Perf Quarter-0.22%
Perf Half Y83.32%
Perf YTD58.46%
Perf Year48.15%
Perf 3Y-0.81%
Perf 5Y-33.57%
Perf 10Y-
Recom3.00
Target Price18.95
Prev Close18.45
Price18.46
Change %0.05%

Analyst ratings

latest 10 of 17
DateActionAnalystRating changeTargetImplied
Aug 17, 2026DowngradeCCJS SecuritiesMarket Outperform → Market Perform
Aug 23, 2024InitiatedRB. Riley SecuritiesBuy$21+13.8%
Oct 12, 2022InitiatedJJefferiesHold$24+30.0%
Feb 05, 2021UpgradeOOppenheimerPerform → Outperform$41+122.1%
Aug 13, 2020DowngradeOOppenheimerOutperform → Perform
May 13, 2020DowngradeJJP MorganOverweight → Neutral$32 → $25+35.4%
Mar 25, 2020UpgradeJJP MorganNeutral → Overweight$32+73.3%
Feb 12, 2020DowngradeJJefferiesBuy → Hold$30+62.5%
Oct 22, 2019InitiatedOOppenheimerOutperform$40+116.7%
Jun 11, 2019UpgradeCCJS SecuritiesMarket Perform → Market Outperform

Peers

Mkt cap
TickerCompanyMkt cap
GEHCGE HealthCare Technologies Inc37.38B
NNOXNano X Imaging Ltd32.31M
PHGKoninklijke Philips NV ADR29.42B
BFLYButterfly Network Inc1.85B
OSISOSI Systems Inc3.09B
BRKRBruker Corp9.68B
TDYTeledyne Technologies Inc30.15B
XRAYDENTSPLY Sirona Inc1.88B
MIRMirion Technologies Inc4.43B
CGNXCognex Corp8.82B

Insider trading

9 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Maheshwari ShubhamChief Financial OfficerSep 11 '26Option Exercise13.61160,9442,190,448269,972Sep 15 05:44 PM
Maheshwari ShubhamChief Financial OfficerSep 11 '26Sale18.46130,0002,400,060139,972Sep 15 05:44 PM
Kunkel Jay K.DirectorSep 14 '26Sale18.488,121150,07615,329Sep 15 05:44 PM
Kunkel Jay K.DirectorSep 14 '26Proposed Sale18.488,121150,076Sep 14 12:14 PM
Maheshwari ShubhamOfficerSep 11 '26Proposed Sale18.46130,0002,400,075Sep 11 04:23 PM
Kunkel Jay K.DirectorMar 20 '26Sale11.144,51050,24123,450Mar 23 04:40 PM
Kunkel Jay K.DirectorMar 20 '26Proposed Sale11.144,51050,241Mar 20 09:52 AM
Honeysett Kimberley E.OfficerDec 11 '25Proposed Sale11.704,00046,800Dec 11 10:48 AM
Honeysett Kimberley E.OfficerNov 21 '25Proposed Sale10.304,00041,200Nov 21 09:39 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
IHIiShares U.S. Medical Devices ETFAUM: 4.07B
FNDASchwab Fundamental U.S. Small Company ETFAUM: 8.98B
FDLSInspire Fidelis Multi Factor ETFAUM: 251.04M

News

latest 14 of 202
  • Are VREX, HZO, SYNA Obtaining Fair Deals for their Shareholders? (PR Newswire)
  • Are VREX, SUNS, PRTH Obtaining Fair Deals for their Shareholders? (PR Newswire)
  • Are ITGR, VREX, HZO, SYNA Obtaining Fair Deals for their Shareholders? (PR Newswire)
  • Are SUNS, VREX, CHMI, FBRX Obtaining Fair Deals for their Shareholders? (PR Newswire)
  • Teledyne agrees to acquire Varex Imaging for $1.1bn (Medical Device Network)
  • Loading…
  • Teledyne inks $1.1B takeover of Varex Imaging (MedTech Dive)
  • Deal Valued At $1.1 Billion Sends This X-Ray Stock Soaring 48% (Investor's Business Daily) +48.75%
  • Varex Q3 FY2026 Results Show Revenue Growth and Margin Expansion Ahead of Teledyne Transaction (InvestorsHub)
  • Stocks to Watch: Berkshire Hathaway, Super Micro Computer, Sunrise Energy (The Wall Street Journal)
  • Why Is VREX Stock Surging Today? (Stocktwits)
  • Teledyne Technologies to Buy Varex Imaging for $1.1 Billion (The Wall Street Journal)
  • Teledyne to acquire Varex Imaging in $1.1 billion deal (Reuters)
  • Varex Announces Financial Results for Third Quarter Fiscal Year 2026 (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-08-100.3100.2100.370210.5215.54
2026Q22026-05-070.2100.210-0.193216216.924
2026Q12026-02-100.1900.1330.054209.6207.794
2025Q42025-11-180.3700.1900.292228.9219.265
2025Q32025-08-070.1800.035-2.147203190.324
2025Q22025-05-080.2600.1250.135212.9206.765
2025Q12025-02-060.0700.023-0.007199.8201.924
2024Q42024-11-190.1900.088-1.223205.7199.434
2024Q32024-08-010.1400.1580.034209.1209.54
2024Q22024-05-020.1600.1950.034206.2205.154
2024Q12024-02-060.0600.103-0.012190187.984
2023Q42023-11-140.4500.3250.632227.4233.384
2023Q32023-08-010.3700.2750.181232.2228.584
2023Q22023-05-020.2600.1500.101228.2215.74
2023Q12023-01-310.2100.1800.076205.6205.684
2022Q42022-11-150.4200.3250.320231.4223.284

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY1.3001.2800.402780.6782.32
2020FY0.0800.018-1.492738.3730.34
2021FY1.3101.0170.432818.1807.29
2022FY1.4301.1630.728859.4851.28
2023FY1.2701.0280.958893.4899.38
2024FY0.5500.448-1.196811804.67
2025FY0.9000.683-1.700844.6834.96
2026FY-0.840--865.9
2027FY-1.070--900.27
2028FY-1.400--965
2029FY-1.900--1,042
2030FY-2.500--1,146

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-09-04300229.79226.98232.7
2026Q4S2026-08-27400229.85226.98232.7
2026Q4S2026-08-17500229.94226.98232.7
2026Q4S2026-08-16401229.25226.98230.3
2026Q4S2026-08-10501229.94226.98232.7
2026Q4S2026-06-04511229.94226.98232.7
2026Q4S2026-06-03511229.94227232.7
2026Q4S2026-05-27410230.68229.7232.7
2026Q4S2026-05-22300230.8229.7232.7
2026Q4S2026-05-08500230.33227.3232.7
2026Q4S2026-02-11500230.63227.3232
2026Q4S2026-02-02500230.5225.1233.5
2026Q4S2026-01-30530230.5225.1233.5
2026Q4S2025-11-19430230.33225.1233.5

Estimate history

EPS, annual1.360.7160.402-1.4920.4320.7280.958-1.196-1.6980.5219
Period201720182019202020212022202320242025TTM
EPS, quarterly0.034-1.223-0.0070.135-2.1470.2920.054-0.1930.369
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual698.1773.4780.6738.3818.1859.4893.4811844.6865
Period201720182019202020212022202320242025TTM
Sales, quarterly209.1205.7199.8212.9203228.9209.6216210.5
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual37.63438.02738.37139.05939.43640.08540.5341.09441.6942.148
Period201720182019202020212022202320242025MRQ
Shares, quarterly40.86141.09441.23141.51341.52141.6941.91942.14642.148
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue865.00844.60811.00893.40859.40818.10738.30780.60773.40
Cost of Goods Sold Incl. D&A568.10554.10554.10603.10575.90533.40528.80503.40500.60
Gross Profit296.90290.50256.90290.30283.50284.70209.50277.20272.80
Selling, General and Administrative Excl. Other224.70224.40224.80213.20193.50196.60211.80199.70200.00
Research and Development91.4091.1087.0084.8077.0071.9078.9078.1083.00
Other Operating Expense0.000.000.000.000.0013.0015.1012.9011.60
Operating Income72.2066.1032.1077.1090.0075.10-17.4064.6061.20
Interest Expense39.3036.3031.1030.2041.0043.4031.4023.2021.80
Unusual Expense-0.5093.10-0.9016.401.801.0018.1017.7016.70
Net Income Before Taxes27.70-59.205.0031.3044.5028.60-72.6021.5025.70
Income Taxes5.2010.7053.30-17.4013.7010.70-15.205.70-2.60
Consolidated Net Income22.50-69.90-48.3048.7030.8017.90-57.4015.8028.30
Net Income From Continuing Operations22.10-70.30-48.8048.2030.3017.40-57.9015.5027.50
Net Income22.10-70.30-48.8048.2030.3017.40-57.9015.5027.50
EPS (Recurring)0.51-0.12-1.211.190.760.45-1.170.721.02
EPS (Basic, Before Extraordinaries)0.53-1.70-1.201.200.760.44-1.490.410.73
EPS (Diluted)0.52-1.70-1.200.960.730.43-1.490.400.72
EBITDA99.5093.3063.20110.30123.60112.4022.10103.80103.40
Non-Operating Income (Expense)-5.704.103.100.80-2.70-2.10-5.70-2.203.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense11.8511.8512.0910.6611.0610.159.788.547.90
Price To Earnings Ratio35.3535.3517.3427.7028.7769.73-66.5426.00
Price To Sales Ratio0.520.590.601.061.021.410.651.401.42
Gross Margin34.3234.3931.6832.4932.9934.8028.3835.5135.27
Operating Margin8.357.833.968.6310.479.18-2.368.287.91
Net Margin2.55-8.32-6.025.403.532.13-7.841.993.56
Shares Outstanding42.1541.6941.0940.5340.0939.4439.0638.3738.03
Market Capitalization783.45783.45487.53759.12843.491,111.08496.811,095.941,089.42

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue210.50216.00209.60228.90203.00212.90199.80205.70
Cost of Goods Sold Incl. D&A133.80143.40139.80151.10135.50136.20131.30138.60
Gross Profit76.7072.6069.8077.8067.5076.7068.5067.10
Selling, General and Administrative Excl. Other53.9058.2054.4058.2054.3054.6057.3056.20
Research and Development23.3022.2021.7024.2021.4022.0023.5021.90
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income22.8014.4015.4019.6013.2022.1011.2010.90
Interest Expense6.0017.307.908.109.6010.408.207.80
Unusual Expense-0.20-0.100.00-0.2093.70-0.20-0.20-0.20
Net Income Before Taxes16.20-6.403.8014.10-86.6010.802.502.50
Income Taxes0.301.601.401.902.503.702.6052.40
Consolidated Net Income15.90-8.002.4012.20-89.107.10-0.10-49.90
Net Income From Continuing Operations15.70-8.102.3012.20-89.106.90-0.30-50.00
Net Income15.70-8.102.3012.20-89.106.90-0.30-50.00
EPS (Recurring)0.37-0.190.050.29-0.570.13-0.01-1.23
EPS (Basic, Before Extraordinaries)0.37-0.190.060.29-2.150.17-0.01-1.22
EPS (Diluted)0.37-0.190.050.29-2.150.13-0.01-1.22
EBITDA29.8021.2022.2026.3020.0028.7018.3017.50
Non-Operating Income (Expense)-0.80-3.60-3.702.403.50-1.10-0.70-0.80
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.003.163.002.692.923.003.242.77
Price To Earnings Ratio35.35------17.34
Price To Sales Ratio0.520.510.580.590.440.510.710.60
Gross Margin36.4433.6133.3033.9933.2536.0334.2832.62
Operating Margin10.836.677.358.566.5010.385.615.30
Net Margin7.46-3.751.105.33-43.893.24-0.15-24.31
Shares Outstanding42.1542.1541.9241.6941.5241.5141.2341.09
Market Capitalization783.45444.56485.81514.60359.81477.92601.56487.53

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments155.10200.50193.90103.90144.60100.6029.9051.9083.30
Short Term Receivables157.40158.40164.30174.20155.30123.80141.00154.00163.60
Inventories299.40264.80277.50303.20224.80271.90248.20235.10234.50
Other Current Assets29.9026.2022.6028.6029.5025.7019.3017.1013.90
Total Current Assets641.80649.90658.30609.90554.20522.00438.40458.10495.30
Net Property, Plant & Equipment187.20181.70172.60164.50164.50172.90142.30144.90148.30
Total Investments and Advances26.6028.5030.4056.1050.8052.8055.0056.5052.30
Intangible Assets212.40307.10310.90318.10342.90360.60377.10317.40333.20
Deferred Tax Assets2.901.3041.302.304.000.50--0.00
Other Assets36.5045.1036.1033.5031.1030.7026.1011.0011.00
Total Assets1,107.401,213.601,249.601,184.401,147.501,139.501,038.90987.901,040.10
Short Term Debt Incl. Current Port. of LT Debt6.3050.705.406.309.208.8030.7025.0020.00
Accounts Payable69.9059.1064.7078.2058.8072.9058.2066.3058.90
Income Tax Payable5.308.1013.3011.308.005.6010.701.4013.20
Other Current Liabilities105.7078.0079.4077.3090.6073.3075.5059.3059.70
Total Current Liabilities187.20195.90162.80173.10166.60160.60175.10152.00151.80
Long Term Debt395.60426.00464.40430.40450.70476.30364.40364.80463.90
Provision for Risks Charges8.608.907.104.606.507.306.404.600.00
Deferred Tax Liabilities5.504.00-0.502.202.308.2023.2029.50
Other Liabilities23.9035.6034.3029.1025.0027.2026.103.904.70
Total Liabilities620.80670.40668.60637.70651.00673.70580.20548.50649.90
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity472.60529.10567.70533.40483.30451.70444.90426.20379.00
Total Shareholders Equity472.60529.10567.70533.40483.30451.70444.90426.20379.00
Accumulated Minority Interest14.0014.1013.3013.3013.2014.1013.8013.2011.20
Total Equity486.60543.20581.00546.70496.50465.80458.70439.40390.20
Total Liabilities & Stockholders Equity1,107.401,213.601,249.601,184.401,147.501,139.501,038.90987.901,040.10
Book Value Per Share11.3412.8814.0113.3112.2611.5611.5911.2110.07
Tangible Book Value Per Share6.245.406.345.373.562.331.772.861.22
Full-Time Employees2,4002,3002,4002,3002,1002,0002,0002,0002,000
Price to Book Ratio1.570.841.431.592.301.102.462.573.55
Return on Assets-6.05-3.963.962.601.52-5.321.532.716.21
Return on Equity-13.95-8.908.755.963.72-12.923.566.8311.40
Return on Invested Capital-8.10-5.114.673.141.86-6.241.923.486.12
Quick Ratio1.831.972.341.771.981.561.091.471.72
Current Ratio3.433.324.043.523.333.252.503.013.26

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income22.50-69.90-48.3048.7030.8017.90-57.4015.8028.30
Depreciation27.3027.2031.1033.2033.6037.3039.5039.2042.20
Other Funds (Non Cash)36.10115.1022.1042.7039.9032.2048.1025.1016.50
Funds from Operations88.7071.9043.0085.10104.9084.4027.1067.2079.30
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-77.40-31.402.0023.30-88.008.20-13.904.706.00
Cash from Operating Activities11.3040.5045.00108.4016.9092.6013.2071.9085.30
Capital Expenditures-31.50-22.90-26.90-20.70-21.30-15.10-23.50-19.80-20.40
Net Assets From Acquisitions0.000.000.90-1.000.000.00-1.60-69.50-4.80
Sale of Fixed Assets and Businesses0.000.000.000.001.700.000.000.001.80
Purchase or Sale of Investments16.3034.80-0.40-27.60-26.90-1.40-1.80-3.90-0.60
Purchase of Investments0.00-30.60-61.00-55.90-28.90-1.40-1.80-3.90-0.60
Sale Or Maturity of Investments16.3065.4060.6028.302.000.000.000.000.00
Other Uses-2.10-1.60-1.10-2.60-1.900.000.000.000.00
Other Sources-0.500.000.007.000.000.300.000.000.00
Cash from Investing Activities-17.8010.30-27.50-44.90-48.40-16.20-26.90-93.20-24.00
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock3.303.303.804.108.702.8054.904.607.10
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock3.303.303.804.108.702.8054.904.607.10
Proceedsfrom Stock Options3.303.303.803.904.902.8053.403.803.30
Issuance or Reduction of Debt, Net-24.70-75.00-1.60-2.40-29.40-31.6093.20-2.10-96.40
Change in Long Term Debt-24.70-75.00-1.60-2.40-29.40-31.6093.20-2.10-96.40
Issuance of Long Term Debt371.00126.900.000.000.001.50577.1084.909.60
Reduction of Long Term Debt-395.70-201.90-1.60-2.40-29.40-33.10-483.90-87.00-106.00
Net Financing Active Other Cash Flow-9.60-3.00-3.20-1.90-3.10-3.50-64.50-2.60-2.90
Other Financing Activities Uses-9.60-3.00-3.20-1.90-3.10-3.50-64.50-2.60-2.90
Cash from Financing Activities-31.00-74.70-1.00-0.20-23.80-32.3083.60-0.10-92.20
Exchange Rate Effect-0.60-0.100.10-0.20-0.100.90-0.70-0.50
Net Change in Cash-37.40-23.3016.4063.40-55.5044.0070.80-22.10-31.40
Free Cash Flow-20.2017.6018.1087.70-4.4077.50-10.3052.1064.90
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow-28.0926.8710.78-14.86-20.9516.96
Deferred Taxes & Investment Tax Credit--0.5038.10-39.500.60-3.00-3.10-12.90-7.70

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments99.2088.30125.60155.10152.60223.00
Short Term Receivables145.50148.90147.30157.40137.80146.50
Inventories347.10346.70328.00299.40298.70284.70
Other Current Assets41.3041.7032.7029.9030.4029.60
Total Current Assets633.10625.60633.60641.80619.50683.80
Net Property, Plant & Equipment197.00192.40189.30187.20176.70177.60
Total Investments and Advances23.7022.4023.5026.6026.70150.30
Intangible Assets210.00211.00213.10212.40213.50305.60
Deferred Tax Assets2.002.902.902.903.003.00
Other Assets34.2035.1035.6036.5034.0037.30
Total Assets1,100.001,089.401,098.001,107.401,073.401,357.60
Short Term Debt Incl. Current Port. of LT Debt23.1023.706.406.305.805.70
Accounts Payable83.5096.4078.9069.9070.7070.80
Income Tax Payable1.800.702.905.303.500.10
Other Current Liabilities79.0074.5074.80105.7096.7092.20
Total Current Liabilities187.40195.30163.00187.20176.70168.80
Long Term Debt356.20357.30394.90395.60391.10591.10
Provision for Risks Charges0.000.000.008.600.000.00
Deferred Tax Liabilities4.505.805.505.502.60-
Other Liabilities41.4042.9043.8023.9033.5033.80
Total Liabilities589.50601.30607.20620.80603.90793.70
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity496.60474.20476.90472.60455.30549.70
Total Shareholders Equity496.60474.20476.90472.60455.30549.70
Accumulated Minority Interest13.9013.9013.9014.0014.2014.20
Total Equity510.50488.10490.80486.60469.50563.90
Total Liabilities & Stockholders Equity1,100.001,089.401,098.001,107.401,073.401,357.60
Book Value Per Share11.7811.2511.3811.3410.9713.24
Tangible Book Value Per Share6.806.246.296.245.825.88
Full-Time Employees---2,400--
Price to Book Ratio1.570.931.031.130.650.89
Return on Assets2.03-6.76-5.57-6.05-11.39-3.22
Return on Equity4.64-16.15-13.31-13.95-25.57-7.46
Return on Invested Capital1.84-0.970.261.41-10.530.60
Quick Ratio1.531.431.871.831.822.36
Current Ratio3.383.203.893.433.514.05

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income15.90-8.002.4012.20-89.107.10
Depreciation7.006.806.806.706.806.60
Other Funds (Non Cash)6.0018.209.102.8096.207.10
Funds from Operations28.5016.9018.9024.4010.5020.90
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-7.50-18.40-35.00-16.50-3.50-4.80
Cash from Operating Activities21.00-1.50-16.107.907.0016.10
Capital Expenditures-9.00-6.20-10.70-5.60-6.30-6.80
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments3.003.104.006.204.8021.70
Purchase of Investments0.000.000.000.000.00-9.20
Sale Or Maturity of Investments3.003.104.006.204.8030.90
Other Uses-0.300.00-1.00-0.800.30-0.20
Other Sources0.000.000.00-0.500.500.00
Cash from Investing Activities-6.30-3.10-7.70-0.70-0.7014.70
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.001.700.001.600.001.70
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.001.700.001.600.001.70
Proceedsfrom Stock Options0.000.000.003.300.000.00
Issuance or Reduction of Debt, Net-1.10-23.200.00-0.40-200.40-0.40
Change in Long Term Debt-1.10-23.200.00-0.40-200.40-0.40
Issuance of Long Term Debt18.50352.500.000.000.000.00
Reduction of Long Term Debt-19.60-375.700.00-0.40-200.40-0.40
Net Financing Active Other Cash Flow-0.10-7.80-1.60-0.10-0.10-1.50
Other Financing Activities Uses-0.10-7.80-1.60-0.10-0.10-1.50
Cash from Financing Activities-1.20-29.30-1.601.10-200.50-0.20
Exchange Rate Effect-0.10--0.300.50-
Net Change in Cash13.40-34.00-25.408.60-193.7030.40
Free Cash Flow12.00-7.70-26.802.300.709.30
Price to Free Cash Flow---28.3610.4011.43

Revenue breakdown

China2024: 118.00M 2025: 128.30M
Japan2024: 118.10M 2025: 143.50M
Other Countries2024: 317.20M 2025: 317.90M
United States2024: 257.70M 2025: 254.90M
Industrial2024: 229.30M 2025: 252.00M
Medical2024: 581.70M 2025: 592.60M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.87%2.0M41.7M888.10K
2026-10-153.91%1.6M41.7M833.44K
2026-09-303.95%1.7M41.7M829.63K
2026-09-153.37%1.4M41.7M830.89K
2026-08-313.02%1.3M41.5M764.38K
2026-08-143.69%1.5M41.4M707.18K
2026-07-312.98%1.2M41.4M452.25K
2026-07-152.92%1.2M41.4M448.76K
2026-06-303.16%1.3M41.4M415.82K
2026-06-153.06%1.3M41.4M362.35K
2026-05-292.84%1.2M41.4M354.60K
2026-05-153.12%1.3M41.4M339.66K
2026-04-303.86%1.6M41.3M313.38K
2026-04-153.35%1.4M41.1M323.20K
2026-03-313.31%1.4M41.1M334.68K
2026-03-133.22%1.3M41.1M340.33K
2026-02-272.86%1.2M41.1M327.36K
2026-02-133.03%1.2M41.1M366.48K
2026-01-301.98%0.8M41.0M318.22K
2026-01-152.15%0.9M41.0M296.98K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5013.8018.100.0023.8640.000.000.994-0.0180.000
call5.0011.4015.600.0012.2300.000.000.990-0.0180.001
call7.509.9013.100.008.6000.000.000.986-0.0180.001
call10.006.909.602.154.7542.000.000.980-0.0170.001
call12.505.008.100.904.8046.000.000.970-0.0160.002
call15.002.654.203.503.3529.000.000.952-0.0140.003
call17.500.601.600.100.9251.000.000.790-0.0220.008
call20.000.000.050.050.38191.000.000.128-0.0150.006
call22.500.002.150.000.7570.000.000.056-0.0140.003
call25.000.002.150.001.0600.000.000.042-0.0150.003
put2.500.000.050.006.0590.000.00-0.006-0.0160.001
put5.000.000.050.003.9740.000.00-0.010-0.0160.001
put7.500.000.050.102.8062.000.00-0.014-0.0160.001
put10.000.000.051.501.9842.000.00-0.020-0.0150.001
put12.500.002.152.201.3911.000.00-0.030-0.0150.002
put15.000.000.100.000.7930.000.00-0.048-0.0120.003
put17.500.000.050.050.28210.000.00-0.311-0.0410.011
put20.000.002.101.502.30112.000.00-0.510-0.1390.012
put22.501.906.200.003.0500.000.00-0.944-0.0110.003
put25.004.408.700.003.5600.000.00-0.958-0.0130.003

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-298-K/A2026-10-28SEC
2026-10-298-KCurrent report2026-10-28SEC
2026-10-22DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-10-228-KCurrent report2026-10-22SEC
2026-10-144Statement of changes in beneficial ownership of securities2026-10-12SEC
2026-10-07SCHEDULE 13G/ASEC
2026-10-05SCHEDULE 13G/ASEC
2026-09-21DEFM14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-11SEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-14144Filing for proposed sale of securities under Rule 144.SEC
2026-09-11144Filing for proposed sale of securities under Rule 144.SEC
2026-09-08PREM14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-09-08SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-12DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-10DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-10DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-10DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-07-03SEC
2026-08-10DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-108-KCurrent report2026-08-10SEC
2026-08-108-KCurrent report2026-08-10SEC
2026-07-31SCHEDULE 13GSEC
2026-05-28SDSpecialized Disclosure ReportSEC
2026-05-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-04-03SEC
2026-05-078-KCurrent report2026-05-07SEC
2026-03-273Initial statement of beneficial ownership of securities2026-02-13SEC
2026-03-27SCHEDULE 13G/ASEC
2026-03-263Initial statement of beneficial ownership of securities2026-02-13SEC
2026-03-234Statement of changes in beneficial ownership of securities2026-03-20SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-09002.55M2
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030050.24K1
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.9.25%
Allspring Global Investments Holdings, LLC5.43%
Neuberger Berman Group LLC4.95%
VANGUARD CAPITAL MANAGEMENT LLC4.44%
PZENA INVESTMENT MANAGEMENT LLC4.20%
FIL Ltd4.00%
RICE HALL JAMES & ASSOCIATES, LLC3.43%
STATE STREET CORP2.65%
GEODE CAPITAL MANAGEMENT, LLC2.56%
ROYCE & ASSOCIATES LP2.31%

Funds

Fund% owned
Allspring Special Small Cap Value Fund3.86%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.20%
iShares Russell 2000 ETF2.60%
BlackRock Event Driven Equity Fund1.41%
THE ARBITRAGE FUND1.41%
Neuberger Intrinsic Value Fund1.39%
Columbia Small Cap Value Discovery Fund1.14%
VANGUARD EXTENDED MARKET INDEX FUND1.14%
Fidelity Small Cap Index Fund1.10%
Fidelity Enhanced Small Cap Core ETF1.03%

OakChart. VREX. Cached 15 minutes.